Jade Biosciences Statistics

Total Valuation

JBIO has a market cap or net worth of $591.15 million. The enterprise value is $627.76 million.

Market Cap	591.15M
Enterprise Value	627.76M

Important Dates

The last earnings date was Thursday, November 13, 2025, before market open.

Earnings Date	Nov 13, 2025
Ex-Dividend Date	n/a

Share Statistics

JBIO has 46.00 million shares outstanding.

Current Share Class	46.00M
Shares Outstanding	46.00M
Shares Change (YoY)	n/a
Shares Change (QoQ)	+39.23%
Owned by Insiders (%)	0.70%
Owned by Institutions (%)	53.17%
Float	29.69M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.81

Current Ratio	5.81
Quick Ratio	5.78
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	-106.04%
Revenue Per Employee	n/a
Profits Per Employee	-$3.13M
Employee Count	30
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	9.80
200-Day Moving Average	n/a
Relative Strength Index (RSI)	67.98
Average Volume (20 Days)	240,026

Short Selling Information

The latest short interest is 1.07 million, so 2.32% of the outstanding shares have been sold short.

Short Interest	1.07M
Short Previous Month	1.03M
Short % of Shares Out	2.32%
Short % of Float	3.60%
Short Ratio (days to cover)	1.20

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-64.48M
Pretax Income	-93.96M
Net Income	-93.96M
EBITDA	n/a
EBIT	-64.48M
Earnings Per Share (EPS)	-$18.79

Full Income Statement

Balance Sheet

The company has $69.39 million in cash and $107.60 million in debt, giving a net cash position of -$38.21 million or -$0.83 per share.

Cash & Cash Equivalents	69.39M
Total Debt	107.60M
Net Cash	-38.21M
Net Cash Per Share	-$0.83
Equity (Book Value)	-46.80M
Book Value Per Share	-8.04
Working Capital	57.66M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-45.23M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

JBIO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-15.94%
FCF Yield	n/a

Dividend Details

Analyst Forecast

The average price target for JBIO is $22.00, which is 71.21% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$22.00
Price Target Difference	71.21%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1